Annual SGA
$26.09 M
-$7.21 M-21.65%
December 31, 2024
Summary
- As of March 3, 2025, ATHA annual SGA is $26.09 million, with the most recent change of -$7.21 million (-21.65%) on December 31, 2024.
- During the last 3 years, ATHA annual SGA has risen by +$4.87 million (+22.92%).
- ATHA annual SGA is now -21.65% below its all-time high of $33.30 million, reached on December 31, 2023.
Performance
ATHA SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$6.20 M
-$1.38 M-18.17%
December 31, 2024
Summary
- As of March 3, 2025, ATHA quarterly SGA is $6.20 million, with the most recent change of -$1.38 million (-18.17%) on December 31, 2024.
- Over the past year, ATHA quarterly SGA has dropped by -$1.38 million (-18.17%).
- ATHA quarterly SGA is now -38.19% below its all-time high of $10.03 million, reached on June 30, 2023.
Performance
ATHA Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.50 B
-$96.94 M-6.93%
December 31, 2024
Summary
- As of March 3, 2025, ATHA TTM SGA is -$1.50 billion, with the most recent change of -$96.94 million (-6.93%) on December 31, 2024.
- Over the past year, ATHA TTM SGA has dropped by -$1.52 billion (-5666.98%).
- ATHA TTM SGA is now -6990.79% below its all-time high of -$21.09 million.
Performance
ATHA TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ATHA Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -21.6% | -18.2% | -5667.0% |
3 y3 years | +22.9% | -18.2% | -5667.0% |
5 y5 years | +1475.7% | -18.2% | -5667.0% |
ATHA Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -21.6% | +22.9% | -38.2% | +5.5% | -416.9% | at low |
5 y | 5-year | -21.6% | +1475.7% | -38.2% | +1249.9% | -6990.8% | at low |
alltime | all time | -21.6% | +1737.5% | -38.2% | +1249.9% | -6990.8% | at low |
Athira Pharma Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $26.09 M(-21.7%) | $6.20 M(-18.2%) | $26.09 M(-2.9%) |
Sep 2024 | - | $7.57 M(+28.9%) | $26.86 M(-1.0%) |
Jun 2024 | - | $5.87 M(-8.9%) | $27.13 M(-13.3%) |
Mar 2024 | - | $6.45 M(-7.3%) | $31.28 M(-6.1%) |
Dec 2023 | $33.30 M(+2.3%) | $6.96 M(-11.2%) | $33.30 M(-2.1%) |
Sep 2023 | - | $7.84 M(-21.8%) | $34.03 M(+2.0%) |
Jun 2023 | - | $10.03 M(+18.3%) | $33.36 M(+3.9%) |
Mar 2023 | - | $8.48 M(+10.2%) | $32.10 M(-1.4%) |
Dec 2022 | $32.55 M | $7.69 M(+7.3%) | $32.55 M(+4.9%) |
Sep 2022 | - | $7.17 M(-18.2%) | $31.02 M(+0.2%) |
Jun 2022 | - | $8.77 M(-1.8%) | $30.97 M(+15.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | $8.93 M(+44.9%) | $26.82 M(+26.3%) |
Dec 2021 | $21.23 M(+216.4%) | $6.16 M(-13.5%) | $21.23 M(+12.0%) |
Sep 2021 | - | $7.12 M(+54.3%) | $18.96 M(+41.4%) |
Jun 2021 | - | $4.61 M(+38.3%) | $13.41 M(+43.1%) |
Mar 2021 | - | $3.34 M(-14.3%) | $9.37 M(+39.7%) |
Dec 2020 | $6.71 M(+305.1%) | $3.89 M(+148.4%) | $6.71 M(+104.8%) |
Sep 2020 | - | $1.57 M(+172.5%) | $3.28 M(+47.7%) |
Jun 2020 | - | $575.00 K(-14.8%) | $2.22 M(+35.0%) |
Mar 2020 | - | $675.00 K(+47.1%) | $1.64 M(+69.7%) |
Dec 2019 | $1.66 M(+16.6%) | $459.00 K(-9.8%) | $968.00 K(+90.2%) |
Sep 2019 | - | $509.00 K | $509.00 K |
Dec 2018 | $1.42 M | - | - |
FAQ
- What is Athira Pharma annual SGA?
- What is the all time high annual SGA for Athira Pharma?
- What is Athira Pharma annual SGA year-on-year change?
- What is Athira Pharma quarterly SGA?
- What is the all time high quarterly SGA for Athira Pharma?
- What is Athira Pharma quarterly SGA year-on-year change?
- What is Athira Pharma TTM SGA?
- What is the all time high TTM SGA for Athira Pharma?
- What is Athira Pharma TTM SGA year-on-year change?
What is Athira Pharma annual SGA?
The current annual SGA of ATHA is $26.09 M
What is the all time high annual SGA for Athira Pharma?
Athira Pharma all-time high annual SGA is $33.30 M
What is Athira Pharma annual SGA year-on-year change?
Over the past year, ATHA annual SGA has changed by -$7.21 M (-21.65%)
What is Athira Pharma quarterly SGA?
The current quarterly SGA of ATHA is $6.20 M
What is the all time high quarterly SGA for Athira Pharma?
Athira Pharma all-time high quarterly SGA is $10.03 M
What is Athira Pharma quarterly SGA year-on-year change?
Over the past year, ATHA quarterly SGA has changed by -$1.38 M (-18.17%)
What is Athira Pharma TTM SGA?
The current TTM SGA of ATHA is -$1.50 B
What is the all time high TTM SGA for Athira Pharma?
Athira Pharma all-time high TTM SGA is -$21.09 M
What is Athira Pharma TTM SGA year-on-year change?
Over the past year, ATHA TTM SGA has changed by -$1.52 B (-5666.98%)